For the application of any rating scale in both clinical practice and research programs, when a value for an item in the scale is missing, the handling of that problem, either by rejecting the rating or creating a surrogate score, is challenging. Different methods have been used to salvage a score when item entries are missing. These include "last value carried forward," a problematic technique because of bias in a disease that is chronically progressing, and simple or multiple imputation strategies, including the prorated score, a technique that can be applied when at least half of the items have complete data and when the items are scaled using only one metric. [1] [2] [3] [4] [5] The prorated score is derived by taking the mean of the observed scores and substituting that value for all of the missing values in the scale. Because the MDS-UPDRS has a consistent metric of 0 to 4 ratings across all items, we sought to test the prorated method using a data-based approach and rigorous threshold for handling missing values in this scale. With access to two large datasets, we investigated the maximum number of missing values allowed while maintaining a near perfect matching with the complete-value score. We used the original validation sample from the English MDS-UPDRS 6, 7 to model the maximal number of missing values for each part that would still allow a valid total score to be Full financial disclosures and author roles may be found in the online version of this article.
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calculated. We then confirmed our findings using the independently derived validation data from the MDS-UPDRS international translation program. 8 
Methods
In the original clinimetric validation analysis of the MDS-UPDRS, 6, 7 we obtained complete scores for 842 English-speaking PD patients. All items that make up the total score were scored on a scale of 0 to 4. The men and women, aged 31 to 98, represented a wide variety of races and ethnicities. 6 Whereas the sample included all Hoehn and Yahr stages (H&Y), the distribution was not equal: stage 1-2, N 5 516; stage 3, N 5 166; and Stage 4-5, N 5 160. To test whether our estimates differed specifically according to disease severity and to control for possible confounds because of sample size differences, we used all scores from stages 4-5 and randomly selected MDS-UPDRS scores from the larger groups (H&Y 1-2 and H&Y 3) so that each of the three samples had 160 individuals (final N 5 480) for this analysis.
The MDS-UPDRS is designed as four separate parts, with summary scores for each to provide an overall severity measure of a given aspect of Parkinson's disease (part I, non-motor experiences of daily living; part II, motor experiences of daily living; part III, motor examination; part IV, motor complications). 6, 7 Our previous work had shown that the parts had to be analyzed separately. 6, 7 To estimate the number of permissible missing values for each part, we first computed the score as the sum of each patient's individual item scores for each part. This score for each part with complete data was used as the gold standard with which the prorated scores based on purposeful deletion of item scores (missing values) could be compared. In this process, the prorated score was calculated as the sum of the available scores multiplied by the number of total items in the complete part of the MDS-UPDRS, and this result was divided by the number of items with actual scores. Comparison between the missing value-based prorated score and the complete score was evaluated using Lin's concordance correlation coefficient (CCC). 9 The CCC measures the exact matching between values (scores generated with all data vs. prorated score with missing values). We set our critical CCC level at 0.95 or greater, interpreted as near-perfect agreement between the missing value-based and the full data-based scores. 9 To accommodate different clinical situations, we applied two approaches to calculate the missing values' prorated scores. First, we systematically omitted a consistent item score (eg, cognitive impairment) for all cases from a given part of the MDS-UPDRS, starting with one missing item and extending up to the maximal number of missing values that still maintained a CCC of 0.95 or greater for all combinations of consistently missing items. This approach modeled the clinical situation of a consistent elimination of items in each part across all patients, as might occur with the practical constraints of field work or telemedicine, in which certain questions could be considered too sensitive to apply outside the office setting, where safety concerns (postural stability) preclude inclusion, or where an item or items are inadvertently excluded in the questionnaire design. We refer to this approach of omitting items as consistently missing.
In the second approach, we omitted a given number of item scores randomly selected across cases (eg, cognition from one patient, hallucinations and psychosis from another), starting with one selected omission and extending up to the maximal number of missing values that retained a CCC of 0.95 or higher. This analysis mimicked a clinical trial or day-to-day clinic encounter in which raters mistakenly overlook items, so that the final sample has missing values that vary across raters and sites. We refer to this approach of omitting items as randomly missing. For the randomly missing approach, the CCC was calculated with 1,000 randomly selected replications of missing items in all combinations for each MDS-UPDRS part.
Because the number of part III items (33) is much higher than the number constituting the other parts (13 in part I, 13 in part II, and 6 in part IV), and because part III has specific right side, left side, and midline assessments, we also examined the part III items with the same techniques, deleting items consistently and randomly, but selecting the deletions from within the item sub-categories:
Midline: speech, facial expression, neck rigidity, arising from chair, gait, freezing, postural stability, posture, global spontaneity, rest tremor of lip/jaw Right Side: upper extremity rigidity, lower extremity rigidity, finger taps, hand movements, pronation-supination, toe taps, leg agility, postural tremor, kinetic tremor, upper extremity rest tremor, lower extremity rest tremor Left Side: upper extremity rigidity, lower extremity rigidity, finger taps, hand movements, pronation-supination, toe taps, leg agility, postural tremor, kinetic tremor, upper extremity rest tremor, lower extremity rest tremor For constancy of rest tremor (item 3.18), we examined all five rest tremor scores and wherever the highest rating resided, we assigned this item to that location (right, left, or midline). For example, if the highest rest tremor score was right upper extremity (RUE), we assigned Constancy of Rest Tremor for that patient to the Right Side domain. If RUE and left upper extremity (LUE) both had the same rating and were higher than all other scores for rest tremor, we assigned constancy of rest tremor to both right and left. If the highest value was seen on right, left, and jaw/lip, we assigned constancy of rest tremor to all three categories.
Our prespecified analytic plan also included a confirmatory step using the samples from all official nonEnglish versions of the MDS-UPDRS. 8, 10, 11 Following the same methodology described earlier, we assembled all cases that were part of the completed official translations (Chinese, Japanese, Estonian, French, Hungarian, Russian, Spanish, Italian, German, and Slovakian; total sample size of 3,784 PD cases). We divided these entries by H&Y stages (stages 1-2, 3, and 4-5). The smallest sample (stage 4-5) was 380 cases and, to equalize the sample sizes of all groups, we randomly selected MDS-UPDRS scores from stage 1-2 and 3 so that each of the three samples had 380 individuals (final N 5 1,140) for the confirmatory analysis. We used the number of acceptable missing values from the original analysis and tested whether the CCC remained at 0.95 or greater for each MDS-UPDRS part in the validation group. As before, we tested the number of allowable missing values for both consistently and randomly missing items.
Results

Consistent Deletion of the Same Item Across All Patients
When given items were consistently dropped from part I of the scale (13 items total; Table 1 ), the minimum CCC remained 0.95 or greater across all H&Y stages for one missing item. With two consistently deleted items, the minimum CCC fell below the 0.95 or greater threshold and did not allow an adequate prorated score to match the actual part I score generated by complete data. Similarly, for part II (13 items total), when any single item was consistently deleted from the data set, the minimum CCC remained 0.95 or greater for all H&Y groups, but an accurate prorated score could not be obtained if two items were consistently absent. For part III (33 items total), across all H&Y stages, three items could be missing, with the minimum CCC remaining 0.95 or greater. In the case of H&Y stages 1-2, for part III, four consistently missing values could be dropped with a maintained accurate score calculation. In contrast, for part IV, all data were essential to include, and even one missed value led to CCC of 0.95 or greater.
Random Deletion of Items
When item scores were deleted at random within a given part, for part I, a total part I score could be validly calculated across all H&Y stages if only one item per patient was missing. In the case of H&Y stages 1-2 and 3, two items could be missing, but in stages 4-5, only one was acceptable with a CCC of 0.95 or greater. For part II, across all HY stages, a total part II score could still be validly calculated if there were two randomly deleted items (Table 2 ). In the case of 
H&Y stages 1-2, three items could be missing and the CCC still remained above threshold, but in stages 3 and 4-5, only two missing values could be tolerated to provide a prorated score that accurately compared with the part II score generated with a full data set. For part III, across all H&Y stages, up to and including seven items could be missing at random with an accurate total part III score still validly calculable. In the case of H&Y stages 1-2 and 3, nine items could be missing, but in stages 4-5, only seven missing values were tolerated and still provided sufficient information, so that the prorated score calculation closely matched the actual part III score based on full data. For part IV, across all H&Y stages, a total part IV score could not be accurately rendered when any randomly missing item was deleted. In the case of H&Y stages 1-2, one item could be missing, but in all other stages, any missing values precluded the calculation of a prorated store that fit with the score generated from the full data set.
Summary of Permissible Missing Values Consistently or Randomly Deleted (Table 3).
In summary, to provide a valid part score that applies across all H&Y stages, the MDS-UPDRS can afford one consistently missing item's value from part I, one from part II, three from part III, but none from part IV (Table 3 ). In contrast, to provide a valid part score that applies across all H&Y stages, the MDS-UPDRS can afford, in a given patient, one randomly missing item's value from part I, two from part II, seven from part III, but none from part IV.
Further Analysis of Part III
When the 33 Part III items were divided into right side items, left side items and midline items (see 
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Methods), these analyses provided fully compatible results to the prior estimates for the number of allowable missing values to those calculated for all H&Y stages considered together (Supplemental Data Table  1 ). If two items assessing right side, two items assessing left side function, or two items assessing midline function were consistently deleted from part III of the MDS-UPDRS, the prorated score calculated by the remaining data accurately generated scores reflective of the same subsection standard score based on the full data set. Further deletions to three missing values in any subsection, however, dropped the minimum CCC below 0.95 for that subsection, indicating that the remaining data did not provide a valid prorated score. When the same analysis was performed with randomly deleted items from within the three part III subsection categories, for all three subsections, if three items from a given section were randomly deleted, the CCC for that subsection remains 0.95 or greater, indicating that a valid score for that section could still be calculated. Further deletions, however, dropped the CCC below threshold, indicating that the MDS-UPDRS loses validity for these sections when more than three missing values occur.
Confirmatory Analysis Using Data Sets From Official MDS-UPDRS Non-English Editions
The confirmatory analysis using the larger sample size from the combined non-English official versions of the MDS-UPDRS (see Methods) confirmed our original findings ( Table 4 ). The number of allowable missing items identified as applicable across all H&Y stages in the original sample was validated for both consistently and randomly deleted items when we tested these values in the combined non-English sample.
To guide clinicians and researchers on how to apply these calculations in a practical setting, several examples are provided (Fig. 1) .
Discussion
Missing data in clinical rating scales are problematic, because assessments are usually time-locked to an office visit and cannot be retrospectively inserted with reliability. Several methods have been developed to handle the problem of missing data, ranging from setting an arbitrary cutoff for the maximum number of missing values to complex imputation methods. [1] [2] [3] [4] [5] However, such strategies serve as guidelines, and validity of any method for a given scale can only be established by testing the techniques against full data sets. Based on a long history of using rating scales to assess Parkinson's disease and with experience in dealing with data sets with missing values, we approached this analysis from two perspectives: first, we recognize that the MDS-UPDRS can be difficult to perform in certain circumstances, such as in field work where untrained professionals may be gathering data, and such items as postural stability (3.11) are not considered safe to perform. Likewise, protocols with intravenous infusions in one arm may compromise the ability to rate parkinsonian features on the encumbered side of the body. In these instances, items may be consistently lost from the data set, creating a dilemma for computing the part III score; second, and a more common problem for practice and clinical trials, items may be inadvertently left unrated, with the specific missing items varying from patient to patient. This problem can affect part Ia, III, and IV, where the investigator may forget to ask a question or evaluate a question, but it also can occur in parts Ib and II if the patient overlooks an item on the questionnaire. In this study, we have identified a clear threshold for how many missing items can exist in each part of the MDS-UPDRS and still allow a solid calculation of a We purposely set our critical CCC at a very high level of agreement between the missing value-based and the gold-standard scores calculated with full data, allowing a maximal mean difference of less than 10%. The method allows for the accurate calculation of total part scores, but it does not allow individual item scores to be generated, except in the case of a single missed value. This focus on part total scores is clinically justified, because patient monitoring is based on total part scores, not individual items. The confirmatory analysis based on the large data set derived from the non-English MDS-UPDRS validation program was uniformally successful in demonstrating that our original calculations were applicable to a fully independent data set.
With the exception of part III, the number of missing items permissible for generating a valid total score was small, suggesting that for parts I, II, and IV, each item is assessing an important feature of the disease without duplicative data. In contrast, for part III, the number of allowable missing items was surprisingly high and, even with our sub-analysis of right side, left side, and midline missing values, allowable missing items exceeded those seen with the other parts. The original team constructing the MDS-UPDRS focused its effort on providing comprehensive, but maximally efficient assessments, but these analyses suggest that future work could focus on the feasibility of a shorter part III with item reductions.
As a strength of our study, we have based our analyses on large and uniformly complete data sets of MDS-UPDRS scores, and we then purposefully dropped item values in different patterns to assess their impact. Our recommendations therefore are based on actual data and not estimates or empiric guidelines. We have constructed our analyses to mimic the two clinically pertinent situations: first, where given items are consistently missed, and second, where items are randomly lost because of error. As limitations, we acknowledge that our method allows a surrogate total part score, but individual items cannot be generated unless only one value is missing. Conversely, the MDS-UPDRS was not constructed for individual item monitoring, and clinical trials and care focus on total part scores. 6, 7 Furthermore, although we selected large datasets that purposefully enrolled patients across severity stages, we cannot ensure that they are representative of all future datasets. Finally, whereas we tested our findings in two independent datasets with full confirmation across all MDS-UPDRS parts, there may be individuals with unusual item scores that do not follow these population patterns for unknown reasons, and therefore the prorated score will not be accurately reflective of the missing value in these individuals. Because these issues are implicit to any imputation technique, future emphasis needs to be placed on techniques to eliminate missing values on the part of raters and patients. Although the methods we used potentially could be applicable to determining the number of permissible missing items for other instruments constructed similarly to the MDS-UPDRS, we emphasize that our findings are applicable only to this scale.
